Department of Pediatrics, University of Utah, Primary Children's Medical Center, Intermountain Medical Center, Murray, UT, USA.
Pediatr Crit Care Med. 2013 Feb;14(2):123-9. doi: 10.1097/PCC.0b013e31826049b3.
To assess the willingness of pediatric intensivists to conduct a pediatric trial of blood glucose control, and to determine if self-reported practices were influenced by adult-specific data over the past 4 yrs. This was a follow-up to our previous 2005 survey.
Electronic survey comprising a 30-item questionnaire.
North American PICUs that were members of, or connected to, the Pediatric Acute Lung Injury and Sepsis Network (n = 96 targeted institutions).
North American pediatric intensivists (n = 209).
None.
We conducted a survey of North American PICUs using a Web-based questionnaire. Invitations were sent to 96 institutions in 37 states/provinces.
Response rate was 68% (141/209). The median definitions of hyperglycemia (150 mg/dL) and hypoglycemia (≤60 mg/dL) were similar to our 2005 survey results. Self-reported practice patterns remain variable. Although 75% of clinician respondents denied a change in clinical practice based on the published literature, the preferred blood glucose target range increased from 80-110 mg/dL in 2005 to 90-140 mg/dL in 2009. Intensivists who preferred a blood glucose target of 80-110 mg/dL decreased from 43% to 6% (p < 0.001). Many respondents (45%) indicated that the acceptable severe hypoglycemia rate (% patients) for a protocol was ≤2.5%. The majority (93%) indicated they would be willing to enroll patients in a pediatric trial of blood glucose control.
Pediatric intensivists report that they control blood glucose with insulin in critically ill children and do not necessarily adopt adult-specific data or a single uniform blood glucose target. The published evidence does not adequately address PICU clinicians concerns. Unanswered questions and persistent variation in practice suggest a need for a multicenter clinical trial of blood glucose control in critically ill children.
评估儿科重症监护医师进行儿童血糖控制试验的意愿,并确定过去 4 年中自我报告的实践是否受到成人特定数据的影响。这是我们之前 2005 年调查的后续。
电子调查包括 30 个项目的问卷。
北美 PICU,是儿科急性肺损伤和脓毒症网络(n=96 家目标机构)的成员或与之相关。
北美儿科重症监护医师(n=209)。
无。
我们对北美 PICU 进行了一项基于网络的问卷调查。邀请发送到 37 个州/省的 96 家机构。
应答率为 68%(141/209)。高血糖(150mg/dL)和低血糖(≤60mg/dL)的中位数定义与我们 2005 年的调查结果相似。自我报告的实践模式仍然存在差异。尽管 75%的临床医生受访者否认根据已发表的文献改变临床实践,但首选的血糖目标范围从 2005 年的 80-110mg/dL 增加到 2009 年的 90-140mg/dL。首选血糖目标为 80-110mg/dL 的重症监护医师从 43%下降到 6%(p<0.001)。许多受访者(45%)表示,协议可接受的严重低血糖发生率(%患者)≤2.5%。大多数(93%)表示他们愿意为儿童血糖控制试验招募患者。
儿科重症监护医师报告他们用胰岛素控制危重病儿童的血糖,不一定采用成人特定数据或单一统一的血糖目标。已发表的证据不能充分解决 PICU 临床医生的担忧。未解决的问题和实践中的持续差异表明,需要在重症儿童中进行血糖控制的多中心临床试验。